site background
Skip to content
Ivy Brain Tumor Center
Trial EligibilityDonate
Main Menu
  • Physicians
  • Industry
  • Ivy Blog
Talk to an Ivy Navigator
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Clinical Trials
    • Current Trials
      • Temsirolimus in Recurrent High-Grade Glioma
      • SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA
      • AZD1390 FOR RECURRENT GRADE IV GLIOMA
      • SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA
      • NIRAPARIB FOR NEWLY DIAGNOSED GLIOBLASTOMA
      • PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
      • ABEMACICLIB PLUS LY3214996 FOR RECURRENT GLIOBLASTOMA
      • INFIGRATINIB FOR RECURRENT HIGH-GRADE GLIOMA
      • RIBOCICLIB FOR RECURRENT GLIOBLASTOMA
      • RIBOCICLIB FOR RECURRENT MENINGIOMA
    • What is a Phase 0 Trial?
    • Why Ivy Clinical Trials?
    • What We Treat
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Ependymomas
      • Craniopharyngiomas
      • Pineal-Region Tumors
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
      • Lodging
      • Transportation
    • Patient Support
    • FAQs
    • Share Your Story
  • Research
    • Scientific Cores
    • Laboratories
      • Mehta Laboratory
      • Tovmasyan Laboratory
      • Tien Laboratory
      • Mirzadeh Laboratory
    • Certifications
    • Preclinical Work
    • Industry Collaboration
    • Published Research
    • Ivy Center Seminar Series
  • About
    • Team
      • Administration
      • Business Operations
      • Clinical Operations
      • Communications
      • Preclinical and Translational Science
      • Clinicians
    • New Ivy Headquarters
    • It’s personal
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us
  • ESPAÑOL

Talk to an Ivy Navigator

602-406-8605
Home » About » Team » Susan Chang, MD
Headshot of Susan Chang

Susan Chang, MD

Scientific Advisory Board Member

Susan Chang, M.D., is Professor in the Department of Neurological Surgery at the University of California at San Francisco (UCSF) and holds the Lai Wan Kan Endowed Chair. She is an investigator in the Brain Tumor Center and is co-leader of the Neuro-Oncology Program at the Helen Diller Family Comprehensive Cancer Center. 

Dr. Chang is an internationally recognized leader in the field of neurological malignancies. She specializes in the treatment of adults with brain tumors, including glioblastomas and meningiomas. Dr. Chang’s major research focus is on the development of novel therapies for brain tumor patients in addition to the assessment of novel imaging markers of prognosis and treatment response. She is the co-principal investigator of a UCSF SPORE project evaluating the role of magnetic resonance spectroscopy in diagnosing tumors and evaluating therapeutic interventions. She is also the principal investigator for a program project grant (P01) focusing on noninvasive markers of molecular subtypes of glioma. She is a member of the executive committee for the Response Assessment in NeuroOncology (RANO) group and has served in many leadership roles in the Society for NeuroOncology including President.  In 2022, Dr. Chang was appointed as Editor-in-Chief of the journal Neuro-Oncology.

Dr. Chang is especially dedicated to improving the experience of her patients and their families, with a particular focus on increasing their quality of life. She is the medical director of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, developed to address the needs of family members and others who care for patients with brain tumors. She is also the co-director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program focused on comprehensive survivorship care for brain tumor patients.

Dr. Chang received her medical degree from the University of British Columbia and completed a residency in internal medicine at Plains Health Centre and Toronto General Hospital. She completed a fellowship in medical oncology at Princess Margaret Hospital in Toronto, as well as a fellowship in neuro-oncology at UCSF, subsequently joining as faculty.

Arial shot of the Ivy Brain Tumor Center
Ivy Brain Tumor Center
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Phase 0 Clinical Trials
    • Why Ivy Clinical Trials?
    • What We Treat
    • Brain Tumor Clinical Trials
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
    • Patient Support
    • FAQs
  • About
    • Team
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us

Stay Updated

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

© Ivy Brain Tumor Center, 2023. All Rights Reserved.
  • Privacy Policy
  • Site Map
Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.